Does your company agree not to file or enforce patents for products used to treat diseases in scope of the Access to Medicines Index (ATMI) in Least Developed Countries (LDCs, as defined by the United Nations), Low Income Countries (LICs, as defined by the World Bank) and Lower-Middle-Income Countries (LMICs, as defined by the World Bank)?